搜索历史记录选项已关闭,请开启搜索历史记录选项。
作者: Pierre-Alain Vitte , Michel Dreano
DOI:
关键词:
摘要: The invention relates to the use a substance signaling through gp130 for manufacture of medicament treatment and/or prevention diabetic neuropathy. IL-6 is preferred.
,2005, 引用: 2
,2004, 引用: 15
,2005, 引用: 0
,2005, 引用: 1
,2008, 引用: 2
,2005, 引用: 4
,2017, 引用: 0
,2019, 引用: 0